论著-头颈部
治疗剂量CT在评价分化型甲状腺癌(DTC)局部淋巴结转移中的价值
作者:常 伟 韩星敏 王瑞华 刘保平 牛广君 张晶晶
所属单位:郑州大学第一附属医院核医学科(河南 郑州 450052)
PDF摘要
目的治疗剂量131ISPECT/CT在评 价分化型甲状腺癌(DTC)局部淋巴结转移 中的价值。方法 回顾性分析我院2016年 1月-2017年12月收治的100例分化型甲状 腺癌患者临床资料。应用SPECT/CT、多 层螺旋CT扫描检查。结果 131I-WBS结果: 300例患者中有110例患者为单纯甲状腺 残留,转移95例,完全去除20例。阳性病 灶共680枚,残留病灶330枚,转移病灶 350枚,其中颈部或纵隔淋巴结转移140 枚,远处转移210枚。SPECT/CT断层融合 显像结果:300例患者经SPECT/CT诊断后 发现,单纯甲状腺残留有120例患者,转 移病例有104例,共有712枚阳性病灶,甲 状腺残留病灶378枚,转移病灶410枚,其 中颈部或纵隔淋巴结转移160枚,远处转 移250枚。患者有淋巴结转移者,通常是 在131I治疗后随访观察淋巴结有无缩小、 增大或者消失,如有复发者,才行穿刺活 检继而手术治疗。二合并肺、骨等远处转 移者,SPECT-CT都是阳性,即可确诊, 无需手术病理。SPECT/CT诊断DTC转移病 灶灵敏度、特异性、准确性显著高于131IWBI(P<0.05)。SPECT/CT淋巴结数、远处 转移、淋巴结检出率、远处转移检出率显 著高于131I-WBI(P<0.05)。结论 SPECT/CT 能显著提高分化型甲状腺癌局部淋巴结转 移诊断率,值得推荐使用。
Objective To investigate the clinical value of radioiodine 131I ablation with SPECT/CT fusion imaging for evaluating lymph node metastasis in differentiated thyroid cancer (DTC). Methods The clinical data of 100 patients with DTC who were admitted to our hospital from January 2016 to December 2017 were retrospectively analyzed, all patients underwent the SPECT/CT fusion imaging and CT examination. Results The 131I-WBI showed that of the 300 patients, 110 patients had simple thyroid residuals, 95 had metastases, and 20 had been completely removed. There were 680 positive lesions including 330 residual lesions, and 350 metastatic lesions, of which 140 lymph nodes metastasis from the neck or mediastinum, and 210 cases of distant metastasis. The SPECT/ CT fusion imaging showed that the there were 120 patients with residual thyroid alone and 104 cases with metastatic disease. There were 712 positive lesions, 378 residual thyroid lesions, and 410 metastatic lesions, of which 160 were cervical or mediastinal lymph node metastases and 250 distant metastases. The surgical results showed that there were 110 cases of simple thyroid residue, 104 cases of metastasis, 398 residual lesions and 413 metastatic lesions, of which 152 were cervical or mediastinal lymph node metastasis and 261 were distant metastasis. The sensitivity, specificity and accuracy of SPECT/CT in diagnosing DTC metastases were significantly higher than those in 131I-WBI (P<0.05). The detection rate of lymph node and distant metastasis in SPECT/CT was significantly higher than that of 131I-WBI (P<0.05). Conclusion SPECT/CT can significantly improve the diagnostic rate of regional lymph node metastasis in differentiated thyroid cancer and is worth recommending.
【关键词】放射性131-I;SPECT/CT;分化型甲状腺癌
【中图分类号】R736.1
【文献标识码】A
【DOI】10.3969/j.issn.1672-5131.2018.08.011
前言
甲状腺癌是内分泌系统最常见的恶性肿瘤,其主要类型是分化型 甲状腺癌。目前,我国分化型甲状腺癌发病率逐年上升,触诊检出率 仅为5%[1];高分辨超声检出率为28%[2],其中甲状腺癌的检出率5%[3]。 目前手术是治疗分化型甲状腺癌主要措施,放射性131碘治疗及TSH抑 制治疗为其辅助措施。分化型甲状腺癌(DTC)是预后较为乐观的恶性 肿瘤之一。DTC占全部甲状腺癌的85%,近些年来呈上升趋势,其中单 侧甲状腺癌最为常见,双侧甲状腺癌次之,多病灶癌灶最少。黄劲雄 等[3]研究认为,多病灶癌在甲状腺乳头状癌中所占比例较高,微小癌 具有极强的隐匿性,术前诊断双侧微小癌的难度极大。分化型甲状腺 癌临床症状不典型,约有81%的患者以颈部肿块或体检发现甲状腺结节 为主要临床表现。甲状腺结节容易合并甲状腺癌、结节性甲状腺肿, 加之该病病理复杂,导致术前确诊率较低。颈部CT是检查甲状腺癌的 常用方法,该检查方法能准确显示病变位置、结节大小及数量[4]、淋 巴结肿大及血供情况。随着近年来影像学迅猛发展,核医学功能影像 与解剖影像的不断融合,SPECT/CT断层成像能综合显示肿瘤位置,判 断肿瘤转移路径,对于评价疗效及预后提供了可靠的评价方法。本文 回顾性分析我院收治的DTC患者,应用SPECT/CT检查诊断,现将研究结果汇报如下。
中国CT和MRI杂志
第16卷, 第 8 期
2018年08月
相关文章